| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Regular Articles |
From the First Department of Pathology,*
Second
Department of Internal Medicine,
and
Department of Chest Medicine,
Chiba
University School of Medicine, Chiba, Japan, and Department of
Molecular and Cellular Biology,§
Medical
Institute of Bioregulation, Kyushu University, Fukuoka, Japan
The cell cycle is governed by a family of cyclin-dependent kinases (Cdks). Cdk2 forms a functional complex with cyclin E and plays a pivotal role in the regulation of G1/S transition. Cdk2 activity is negatively regulated by interactions with inhibitors. p27Kip1, one of the most potent inhibitors of Cdk2, was recently identified as a powerful negative prognostic marker in non-small cell lung cancer as well as in colorectal and breast cancer. In the present study, the expression of p27 and Ki-67 antigen in nonneoplastic and cancerous lung tissues was determined by immunohistochemistry. After establishing that the antibody-measured p27 labeling index was a good reflection of the level of p27 expression measured by Western blotting, we show that p27 labeling index is decreased in cancerous lung tissues, compared with nonneoplastic lung tissues, and exhibits a significant inverse relation to the proliferation marker Ki-67 antigen, detected with monoclonal antibody MIB-1. Consistent with these data, all cancerous lung tissues showed enhanced degradation activity of p27 compared with nonneoplastic lung tissues and, in addition, increased levels of the phosphorylated form of Cdk2, as determined with Western blot analysis. The H1 histone kinase activity associated with Cdk2 was also increased in non-small cell lung cancers. Statistical analysis showed that proliferative activity as measured by MIB-1 labeling index was highly correlated with Cdk2 activity (r = 0.767, P < 0.0015). These results suggest that p27 and Cdk2 may play an important role in the proliferation of non-small cell cancer.
This article has been cited by other articles:
 |
|
 |
|
  H. Kawana, H. Karaki, M. Higashi, M. Miyazaki, F. Hilberg, M. Kitagawa, and K. Harigaya CD44 Suppresses TLR-Mediated Inflammation J. Immunol., March 15, 2008; 180(6): 4235 - 4245. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Soo, J Wu, A Aggarwal, Q Tao, W Hsieh, T Putti, K. Tan, W. Soon, Y. Lai, B Mow, et al. Celecoxib reduces microvessel density in patients treated with nasopharyngeal carcinoma and induces changes in gene expression Ann. Onc., November 1, 2006; 17(11): 1625 - 1630. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Timmerbeul, C. M. Garrett-Engele, U. Kossatz, X. Chen, E. Firpo, V. Grunwald, K. Kamino, L. Wilkens, U. Lehmann, J. Buer, et al. Testing the importance of p27 degradation by the SCFskp2 pathway in murine models of lung and colon cancer PNAS, September 19, 2006; 103(38): 14009 - 14014. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Kotoshiba, T. Kamura, T. Hara, N. Ishida, and K. I. Nakayama Molecular Dissection of the Interaction between p27 and Kip1 Ubiquitylation-promoting Complex, the Ubiquitin Ligase That Regulates Proteolysis of p27 in G1 Phase J. Biol. Chem., May 6, 2005; 280(18): 17694 - 17700. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Kotake, K. Nakayama, N. Ishida, and K. I. Nakayama Role of Serine 10 Phosphorylation in p27 Stabilization Revealed by Analysis of p27 Knock-in Mice Harboring a Serine 10 Mutation J. Biol. Chem., January 14, 2005; 280(2): 1095 - 1102. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Matsuda, T. Ichida, T. Genda, S. Yamagiwa, Y. Aoyagi, and H. Asakura Loss of p16 Contributes to p27 Sequestration by Cyclin D1-Cyclin-dependent Kinase 4 Complexes and Poor Prognosis in Hepatocellular Carcinoma Clin. Cancer Res., August 1, 2003; 9(9): 3389 - 3396. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Fiorentino, A. Altimari, A. D'Errico, E. Gabusi, P. Chieco, M. Masetti, and W. F. Grigioni Low p27 Expression Is an Independent Predictor of Survival for Patients with Either Hilar or Peripheral Intrahepatic Cholangiocarcinoma Clin. Cancer Res., December 1, 2001; 7(12): 3994 - 3999. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K.-H. Park, J. Y. Seol, T.-Y. Kim, C.-G. Yoo, Y. W. Kim, S. K. Han, Y.-S. Shim, and C.-T. Lee An Adenovirus Expressing Mutant p27 Showed More Potent Antitumor Effects Than Adenovirus-p27 Wild Type Cancer Res., August 1, 2001; 61(16): 6163 - 6169. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D.-Z. J. Liao, X. Hou, S. Bai, S. Antonia Li, and J. J. Li Unusual deregulation of cell cycle components in early and frank estrogen-induced renal neoplasias in the Syrian hamster Carcinogenesis, December 1, 2000; 21(12): 2167 - 2173. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Fiorentino, A. Altimari, A. D’Errico, B. Cukor, C. Barozzi, M. Loda, and W. F. Grigioni Acquired Expression of p27 Is a Favorable Prognostic Indicator in Patients with Hepatocellular Carcinoma Clin. Cancer Res., October 1, 2000; 6(10): 3966 - 3972. [Abstract] [Full Text]
|
|
|
|
|
|
F. Hommura, H. Dosaka-Akita, T. Mishina, M. Nishi, T. Kojima, H. Hiroumi, S. Ogura, M. Shimizu, H. Katoh, and Y. Kawakami Prognostic Significance of p27KIP1 Protein and Ki-67 Growth Fraction in Non-small Cell Lung Cancers Clin. Cancer Res., October 1, 2000; 6(10): 4073 - 4081. [Abstract] [Full Text]
|
|
|
|
 |
|
 F. Mouriaux, C.-A. Maurage, P. Labalette, B. Sablonnière, F. Malecaze, and J.-M. Darbon Cyclin-Dependent Kinase Inhibitory Protein Expression in Human Choroidal Melanoma Tumors Invest. Ophthalmol. Vis. Sci., September 1, 2000; 41(10): 2837 - 2843. [Abstract] [Full Text]
|
|
|
|
 |
|
 A. M. Oliveira, A. G. Nascimento, S. H. Okuno, and R. V. Lloyd p27kip1 Protein Expression Correlates With Survival in Myxoid and Round-Cell Liposarcoma J. Clin. Oncol., August 15, 2000; 18(15): 2888 - 2893. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Takano, Y. Kato, P. J. van Diest, M. Masuda, H. Mitomi, and I. Okayasu Cyclin D2 Overexpression and Lack of p27 Correlate Positively and Cyclin E Inversely with a Poor Prognosis in Gastric Cancer Cases Am. J. Pathol., February 1, 2000; 156(2): 585 - 594. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Shirane, Y. Harumiya, N. Ishida, A. Hirai, C. Miyamoto, S. Hatakeyama, K.-i. Nakayama, and M. Kitagawa Down-regulation of p27Kip1 by Two Mechanisms, Ubiquitin-mediated Degradation and Proteolytic Processing J. Biol. Chem., May 14, 1999; 274(20): 13886 - 13893. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. V. Lloyd, L. A. Erickson, L. Jin, E. Kulig, X. Qian, J. C. Cheville, and B. W. Scheithauer p27kip1: A Multifunctional Cyclin-Dependent Kinase Inhibitor with Prognostic Significance in Human Cancers Am. J. Pathol., February 1, 1999; 154(2): 313 - 323. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Ishida, M. Kitagawa, S. Hatakeyama, and K.-i. Nakayama Phosphorylation at Serine 10, a Major Phosphorylation Site of p27Kip1, Increases Its Protein Stability J. Biol. Chem., August 11, 2000; 275(33): 25146 - 25154. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
